Press release
Macrolide Antibiotics Market Report 2018 - GlaxoSmithKline, Johnson & Johnson, Bayer, Abbott Laboratories, Novartis, Sanofi, AstraZeneca, Roche Holding AG, Macrolide Pharmaceuticals, Inc., SM Biomed, Sandoz
An exclusive Macrolide Antibiotics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Macrolide Antibiotics Market By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin), By Route of Administration (Oral, Parenteral), By Infection (Mycoplasma pneumoniae, Legionella sp., Or Bordetella pertussis,Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis, Uncomplicated Skin Infections), By End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Center, Research Laboratories), By Geography. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the Global Macrolide Antibiotics Market. Additionally, the report also highlights market entry strategies for various companies across the globe.The List of Companies:
• Merck Co. & Inc.
• Pfizer Inc.
• Sandoz International GmbH
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc.
• Bayer AG
• Abbott
• Novartis AG
• Sanofi
• AstraZeneca
• F. Hoffmann-La Roche AG
• Cempra, Inc.
• Macrolide Pharmaceuticals, Inc.
• SM Biomed
• Barkat Pharmaceutical Group
• Active Pharmaceutical Ingredient Manufacturing
• Mustafa NevzatİlaçSanayii A.Ş.
• Zhejiang Guobang Pharmaceutical Co., Ltd.
• Tianyin Pharmaceutical Co., Inc.
• Japan Pharmaceutical Manufacturers Association(JPMA)
• Murli Krishna Pharma
• Among others.
Click here to Grab the SAMPLE Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-macrolide-antibiotics-market
Market Analysis: Global Macrolide Antibiotics Market
The Global Macrolide Antibiotics Market accounted to grow at a CAGR of 12.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Table of Contents -
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports
Access Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-macrolide-antibiotics-market
The global macrolide antibiotics market is segmented by drugs into:
• Azithromycin
• Clarithromycin
• Erythromycin
• Fidaxomicinand Telithromycin
On the basis of route of administration the market is segmented into:
• Oral
• Parenteral
On the basis of indication the market is segmented into:
• Infection Due To Mycoplasma Pneumoniae
• Legionella Sp.
• Bordetella Pertussis
• Symptomatic Cat-Scratch Disease
• Bacillaryangiomatosis
• Peliosishepatis In Patients With AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections And Others.
On the basis of end user, the market is segmented into:
• Hospital
• Dermatology Clinic
• Clinic
• Ambulatory Center
• Research Laboratories
On the basis of geography, global macrolide antibiotics market report covers data points for 28 countries across multiple geographies such as,
• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
To Make an Inquiry @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-macrolide-antibiotics-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Macrolide Antibiotics Market Report 2018 - GlaxoSmithKline, Johnson & Johnson, Bayer, Abbott Laboratories, Novartis, Sanofi, AstraZeneca, Roche Holding AG, Macrolide Pharmaceuticals, Inc., SM Biomed, Sandoz here
News-ID: 1518137 • Views: …
More Releases from Data Bridge Market Research
Europe Epigenetics Diagnostic Market Size Projected to Hit USD 5.43 billion by 2 …
Market Summary
As per Data Bridge Market Research analysis, the Europe Epigenetics Diagnostic Market was estimated at USD 2.34 billion in 2025. The market is expected to grow from USD 2.08 billion in 2024 to USD 5.43 billion by 2032, at a CAGR of 12.70% during the forecast period driven by the rising demand for early-stage precision oncology, expanding utilization of non-invasive liquid biopsy platforms, increasing research investments in histone modification…
Age-Related Macular Degeneration (AMD) Anti-VEGF Therapeutics Market: Industry A …
Market Summary
As per Data Bridge Market Research analysis, the Age-Related Macular Degeneration (AMD) Disease - Anti-VEF Market was estimated at USD 15.59 billion in 2025. The market is expected to grow from USD 16.65 billion in 2026 to USD 24.71 billion in 2032, at a CAGR of 6.80% during the forecast period with driven by the rising demand for effective retinal disease therapies, increasing prevalence of age-related vision disorders, advancements…
Yogurt Powder Market Size Expected to Reach USD 1.41 Billion by 2032 at a CAGR o …
Market Summary
As per Data Bridge Market Research analysis, the Yogurt Powder Market was estimated at USD 0.28 billion in 2025. The market is expected to grow from USD 0.30 billion in 2026 to USD 1.41 billion in 2032, at a CAGR of 8.10% during the forecast period with driven by the rising demand for shelf-stable dairy ingredients, growing consumption of functional and protein-enriched foods, expansion of the food processing industry,…
Pressure Transmitter Market Size, Share & Industry Trends Analysis Report - Glob …
As per Data Bridge Market Research analysis, the Pressure Transmitter Market was estimated at USD 3.41 billion in 2025. The market is expected to grow from USD 3.54 billion in 2026 to USD 4.44 billion in 2032, at a CAGR of 3.86% during the forecast period (2026-2032), driven by the rising demand for industrial automation, increasing adoption of Industry 4.0 technologies, expansion of oil & gas and process industries, and…
More Releases for Macrolide
Emerging Sub-Segments Transforming the Macrolide Antibiotics Market Landscape
The macrolide antibiotics market is on track for impressive growth in the coming years, driven by evolving healthcare needs and advancements in treatment approaches. This sector is experiencing increasing demand due to various healthcare challenges and improving access to medications globally. Below is a detailed overview of the market's size, key players, trends, and segmentation.
Anticipated Market Expansion in the Macrolide Antibiotics Sector by 2030
The macrolide antibiotics market is…
Rising Prevalence Of Skin Infections Fuels Growth In The Macrolide Antibiotics M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Macrolide Antibiotics Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a quick expansion in the market size of macrolide antibiotics. It is projected to surge from $59.07 billion in 2024 to $66.02 billion in 2025, with a Compound Annual Growth Rate (CAGR)…
Macrolide Drugs Market: A Comprehensive Overview
The global macrolide drugs market was valued at approximately USD 5.60 billion in 2024 and is expected to reach around USD 6.82 billion by 2033, growing at a compound annual growth rate (CAGR) of 2.0% from 2025 to 2033.
Macrolide Drugs Market Overview
Macrolide antibiotics, including azithromycin, clarithromycin, and erythromycin, are widely used in the treatment of respiratory tract infections, skin infections, and sexually transmitted diseases. Their broad-spectrum activity and favorable safety…
Emerging Macrolide Antibiotics Market Trend 2025-2034: Growing Emphasis On Gener …
"How Is the Macrolide Antibiotics Market Projected to Grow, and What Is Its Market Size?
The market size for macrolide antibiotics has seen a swift expansion in the past few years. It is expected to elevate from a value of $59.07 billion in 2024 to $66.02 billion in 2025, marking a compound annual growth rate (CAGR) of 11.8%. The preceding period's growth is associated with factors like escalating antibiotic resistance, authorization…
Defending Health: Global Macrolide Antibiotics Market Analysis 2023-2031
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Macrolide antibiotics have long been stalwarts in the fight against bacterial infections, offering potent and versatile solutions to a wide range of ailments. As the world faces evolving challenges in infectious disease management, the global macrolide antibiotics market is poised to undergo significant growth, driven by technological advancements, increasing antibiotic resistance, and the impact of the COVID-19 pandemic.
𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
…
Macrolide Antibiotics Market Greater Revenue Share by 2026(Macrolide Antibiotics …
Macrolide Antibiotics are bacteriostatic in nature with a broad spectrum of activity against many gram-positive bacteria. Macrolide Antibiotics are primarily useful in treating soft tissue, respiratory condition, sexually transmitted and atypical mycobacterial infections. Macrolide Antibiotics also possess anti-inflammatory and immunomodulatory effects which are used for certain health conditions. Macrolide Antibiotics are considered to be both first line and second line of treatment, it mainly depends on the conditions it is…
